Experiments in ALS mice engineered with mutations in the genes encoding the transactive response DNA-binding protein (TARDBP) and proteins fused-in-sarcoma (FUS) have demonstrated that axonal transport deficits are prodromal features of the disease and contribute to motor dysfunction and loss of neuromuscular integrity [71]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.